Pretty soon, Pfizer CEO Albert Bourla will have all the “data” he needs to justify another round of “mandatory” boosters.

“According to the same data gleaned from the blood plasma taken from 12 patients who tested positive for omicron, the team found that a two-shot course of Pfizer’s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, though it can thwart severe disease, according to laboratory experiments in South Africa, according to Bloomberg.”

But it matters less anyway, since any patient – even an unvaccinated one – has less to fear from omicron. The reason being is that it’s believed to cause a more mild, “flu-like” infection.”

https://www.zerohedge.com/covid-19/pfizer-jab-only-23-against-omicron-south-african-study-finds